Skip to content

Progestin-Only Pill Use and Breastfeeding Study

Progestin-Only Pill Use and Breastfeeding Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04965116
Enrollment
30
Registered
2021-07-16
Start date
2021-10-25
Completion date
2022-11-04
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, Contraception

Keywords

Minipill, Progestin-only Pill, Postpartum, Slynd, Camila, Micronor, Infant growth, Breastmilk, Drospirenone, Norethindrone

Brief summary

This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.

Detailed description

This is a placebo-controlled randomized controlled trial enrolling dyads of birthing people and their newborn infants. We will explore if the type and timing of initiation of pills is acceptable to the user with minimal side effects, impacts the supply or composition of breastmilk, and/or affects infant growth. Birthing people will be randomly assigned to 1 of 3 groups and will be blinded to group assignment: 1. immediate initiation of drospirenone-containing progestin-only pills (d-POPs), 2. immediate initiation of norethindrone-containing progestin-only pills (n-POPs) 3. immediate initiation of a placebo pill for one month followed by d-POPs.

Interventions

DRUGProgestin Only Contraceptive Pills

Daily pill (placebo or active tablet)

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age and older * Desires to use POPs for 3 months * Speak English or Spanish * Had a vaginal or cesarean delivery of a singleton full term (≥37 weeks) infant less than 168 hours prior * Intends to breastfeed exclusively for 6 months

Exclusion criteria

* Desire another pregnancy in less than 6 months * Do not intend to exclusively breastfeed * Do not have access to a telephone * Have any medical contraindication to POPs * Have any contraindication to breastfeeding, including maternal illegal drug use, history of augmentation or reduction, infant with major congenital anomaly * Cognitively impaired * Currently incarcerated

Design outcomes

Primary

MeasureTime frameDescription
Exclusive Lactation Among Birthing People at 8 Weeks Postpartum.8 weeks postpartumLactation status will be assessed at 8 weeks postpartum through an email self-reported survey.

Secondary

MeasureTime frameDescription
Vaginal Bleeding8 weeks postpartumNumber of days of any bleeding and spotting among birthing people in last week will be collected via self-reported email survey.
Satisfaction With Assigned POP8 weeks postpartumOverall satisfaction and if birthing people would recommend the POP they were assigned to use to a friend will be ascertained from an email self-report survey. Counts are the number of birthing people who responded yes.
Protein Content of Human Milk4 weeks postpartumMid-feeding milk samples will be pumped by birthing people and analyzed.
Carbohydrate Content of Human Milk4 weeks postpartumMid-feeding milk samples will be pumped by birthing people and analyzed.
Proportion of Birthing People Using Progestin-only Pills at 8 Weeks Postpartum8 weeks postpartumType of contraception being used at 8 weeks postpartum will be assessed through an email self-reported survey.
Perception of Milk Supply8 weeks postpartumSelf-reported perception of adequacy of milk supply will be collected with the 20-item Hill and Humenick Lactation Scale among birthing people. Minimum scale score is 20 and maximum is 140, with higher scores representing a more positive perception of breastfeeding.
Change in Infant WeightBaseline and 4 weeks after deliveryInfant weight in grams will be compared over 4 weeks.
Change in Infant HeightBaseline and 4 weeks after deliveryInfant length as measured on a marked board to the nearest millimeter will be compared over 4 weeks.
Change in Infant Head CircumferenceBaseline and 4 weeks after deliveryThe maximum diameter through the infant's glabella and occiput is found and measured with a tape measure and recorded to the nearest millimeter and compared over 4 weeks.
Fat Content of Human Milk4 weeks postpartumMid-feeding milk samples will be pumped by birthing people and analyzed.

Countries

United States

Participant flow

Pre-assignment details

Numbers represent dyads of the birthing person and infant.

Participants by arm

ArmCount
Early Initiation d-POPs
Initiation of d-POPs 120-160 hours after delivery. Dosing is 4mg daily for 24 days followed by 4 daily inactive tablets for 2 months. Progestin Only Contraceptive Pills: Daily pill (placebo or active tablet)
10
Early Initiation n-POPs
Initiation of n-POPs 120-160 hours after delivery. Dosing is 0.35mg daily for 28 days for 2 months. Progestin Only Contraceptive Pills: Daily pill (placebo or active tablet)
10
Interval Initiation of d-POPs
Placebo starting 120-160 hours after delivery, continuing for 28 days. Followed by 24 days of 4mg daily of d-POPs and 4 daily inactive tablets. Progestin Only Contraceptive Pills: Daily pill (placebo or active tablet)
10
Total30

Baseline characteristics

CharacteristicEarly Initiation d-POPsTotalInterval Initiation of d-POPsEarly Initiation n-POPs
Age, Continuous31.6 years
STANDARD_DEVIATION 5.6
30.4 years
STANDARD_DEVIATION 5.6
28.4 years
STANDARD_DEVIATION 3.6
31.2 years
STANDARD_DEVIATION 5.5
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants12 Participants5 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants18 Participants5 Participants7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Highest education level achieved
Completed graduate degree
2 Participants7 Participants3 Participants2 Participants
Highest education level achieved
High school or less
1 Participants3 Participants1 Participants1 Participants
Highest education level achieved
Post-high school, technical school
0 Participants1 Participants0 Participants1 Participants
Highest education level achieved
Some college
2 Participants5 Participants3 Participants0 Participants
Highest education level achieved
Some graduate degree
0 Participants1 Participants1 Participants0 Participants
Highest education level achieved
Undergraduate degree
5 Participants13 Participants2 Participants6 Participants
Infant birth head circumference34.3 Centimeters
STANDARD_DEVIATION 1.7
34.74 Centimeters
STANDARD_DEVIATION 1.4
35.0 Centimeters
STANDARD_DEVIATION 0.7
34.9 Centimeters
STANDARD_DEVIATION 1.5
Infant birth length51.2 Centimeters
STANDARD_DEVIATION 2.1
51.06 Centimeters
STANDARD_DEVIATION 2.3
50.4 Centimeters
STANDARD_DEVIATION 2.2
51.6 Centimeters
STANDARD_DEVIATION 2.7
Infant birth weight3432 Grams
STANDARD_DEVIATION 546
3456 Grams
STANDARD_DEVIATION 453
3502 Grams
STANDARD_DEVIATION 484
3433 Grams
STANDARD_DEVIATION 354
Infant sex at birth
Female
6 Infants of the dyad15 Infants of the dyad3 Infants of the dyad6 Infants of the dyad
Infant sex at birth
Male
4 Infants of the dyad15 Infants of the dyad7 Infants of the dyad4 Infants of the dyad
Prior delivery2 Participants9 Participants4 Participants3 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants7 Participants2 Participants3 Participants
Race (NIH/OMB)
Black or African American
1 Participants2 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants0 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants6 Participants2 Participants1 Participants
Race (NIH/OMB)
White
3 Participants13 Participants6 Participants4 Participants
Region of Enrollment
United States
10 birthing person/infant dyad30 birthing person/infant dyad10 birthing person/infant dyad10 birthing person/infant dyad
Sex: Female, Male
Female
10 Participants30 Participants10 Participants10 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants
Using donor milk to supplement feeding in hospital4 Participants9 Participants4 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 200 / 20
other
Total, other adverse events
0 / 200 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 200 / 20

Outcome results

Primary

Exclusive Lactation Among Birthing People at 8 Weeks Postpartum.

Lactation status will be assessed at 8 weeks postpartum through an email self-reported survey.

Time frame: 8 weeks postpartum

Population: Lactation status was reported by 22 birthing people at 8 weeks.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Early Initiation d-POPsExclusive Lactation Among Birthing People at 8 Weeks Postpartum.7 Participants
Early Initiation n-POPsExclusive Lactation Among Birthing People at 8 Weeks Postpartum.7 Participants
Interval Initiation of d-POPsExclusive Lactation Among Birthing People at 8 Weeks Postpartum.6 Participants
Secondary

Carbohydrate Content of Human Milk

Mid-feeding milk samples will be pumped by birthing people and analyzed.

Time frame: 4 weeks postpartum

Population: 20 total milk samples collected.

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsCarbohydrate Content of Human Milk9.11 ng/dLStandard Deviation 0.61
Early Initiation n-POPsCarbohydrate Content of Human Milk8.75 ng/dLStandard Deviation 0.4
Interval Initiation of d-POPsCarbohydrate Content of Human Milk9.25 ng/dLStandard Deviation 1.02
Secondary

Change in Infant Head Circumference

The maximum diameter through the infant's glabella and occiput is found and measured with a tape measure and recorded to the nearest millimeter and compared over 4 weeks.

Time frame: Baseline and 4 weeks after delivery

Population: 20 infants measured.

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsChange in Infant Head Circumference8.4 Percent differenceStandard Deviation 5
Early Initiation n-POPsChange in Infant Head Circumference7.3 Percent differenceStandard Deviation 3.8
Interval Initiation of d-POPsChange in Infant Head Circumference7.4 Percent differenceStandard Deviation 3.5
Secondary

Change in Infant Height

Infant length as measured on a marked board to the nearest millimeter will be compared over 4 weeks.

Time frame: Baseline and 4 weeks after delivery

Population: 20 infants measured.

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsChange in Infant Height7.2 Percent differenceStandard Deviation 2.6
Early Initiation n-POPsChange in Infant Height3.6 Percent differenceStandard Deviation 4
Interval Initiation of d-POPsChange in Infant Height6.8 Percent differenceStandard Deviation 6.1
Secondary

Change in Infant Weight

Infant weight in grams will be compared over 4 weeks.

Time frame: Baseline and 4 weeks after delivery

Population: 20 infants weighed.

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsChange in Infant Weight20.9 Percent differenceStandard Deviation 13.1
Early Initiation n-POPsChange in Infant Weight28.4 Percent differenceStandard Deviation 9
Interval Initiation of d-POPsChange in Infant Weight30.8 Percent differenceStandard Deviation 18.7
Secondary

Fat Content of Human Milk

Mid-feeding milk samples will be pumped by birthing people and analyzed.

Time frame: 4 weeks postpartum

Population: 20 total milk samples collected

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsFat Content of Human Milk3.79 ng/dLStandard Deviation 0.71
Early Initiation n-POPsFat Content of Human Milk3.53 ng/dLStandard Deviation 1.14
Interval Initiation of d-POPsFat Content of Human Milk3.24 ng/dLStandard Deviation 0.61
Secondary

Perception of Milk Supply

Self-reported perception of adequacy of milk supply will be collected with the 20-item Hill and Humenick Lactation Scale among birthing people. Minimum scale score is 20 and maximum is 140, with higher scores representing a more positive perception of breastfeeding.

Time frame: 8 weeks postpartum

Population: Perception of milk supply was reported by 22 birthing people at 8 weeks.

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsPerception of Milk Supply95.1 Mean scale scoreStandard Deviation 8
Early Initiation n-POPsPerception of Milk Supply96.5 Mean scale scoreStandard Deviation 7.9
Interval Initiation of d-POPsPerception of Milk Supply92.5 Mean scale scoreStandard Deviation 6.7
Secondary

Proportion of Birthing People Using Progestin-only Pills at 8 Weeks Postpartum

Type of contraception being used at 8 weeks postpartum will be assessed through an email self-reported survey.

Time frame: 8 weeks postpartum

Population: Progestin-only pill use was reported by 22 birthing people at 8 weeks.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Early Initiation d-POPsProportion of Birthing People Using Progestin-only Pills at 8 Weeks Postpartum7 Participants
Early Initiation n-POPsProportion of Birthing People Using Progestin-only Pills at 8 Weeks Postpartum8 Participants
Interval Initiation of d-POPsProportion of Birthing People Using Progestin-only Pills at 8 Weeks Postpartum4 Participants
Secondary

Protein Content of Human Milk

Mid-feeding milk samples will be pumped by birthing people and analyzed.

Time frame: 4 weeks postpartum

Population: 20 total milk samples were collected.

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsProtein Content of Human Milk1.49 ng/dLStandard Deviation 0.18
Early Initiation n-POPsProtein Content of Human Milk1.46 ng/dLStandard Deviation 0.29
Interval Initiation of d-POPsProtein Content of Human Milk1.26 ng/dLStandard Deviation 0.28
Secondary

Satisfaction With Assigned POP

Overall satisfaction and if birthing people would recommend the POP they were assigned to use to a friend will be ascertained from an email self-report survey. Counts are the number of birthing people who responded yes.

Time frame: 8 weeks postpartum

Population: Satisfaction with assigned POP was reported by 22 birthing people at 8 weeks.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Early Initiation d-POPsSatisfaction With Assigned POP6 Participants
Early Initiation n-POPsSatisfaction With Assigned POP8 Participants
Interval Initiation of d-POPsSatisfaction With Assigned POP5 Participants
Secondary

Vaginal Bleeding

Number of days of any bleeding and spotting among birthing people in last week will be collected via self-reported email survey.

Time frame: 8 weeks postpartum

Population: Vaginal bleeding was reported by 22 birthing people at 8 weeks.

ArmMeasureValue (MEAN)Dispersion
Early Initiation d-POPsVaginal Bleeding0.1 daysStandard Deviation 0.4
Early Initiation n-POPsVaginal Bleeding2.7 daysStandard Deviation 3.1
Interval Initiation of d-POPsVaginal Bleeding0.2 daysStandard Deviation 0.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026